For early-stage life sciences and health tech companies, raising capital is about more than demonstrating scientific promise. Investors are increasingly focused on regulatory preparedness, reimbursement strategy, and risk...more
The life sciences industry is built on breakthroughs and partnerships. From early-stage biotech startups to established medtech and pharma companies, success often depends on navigating complex business transactions, securing...more
Exiting a business, whether you are a serial entrepreneur looking to move on to the next project or a healthcare provider like a physician or therapist who has nurtured your practice for decades, can be difficult. After all,...more
7/9/2024
/ Business Ownership ,
Buyers ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Due Diligence ,
Exit Strategies ,
Federal Trade Commission (FTC) ,
Hart-Scott-Rodino Act ,
Healthcare ,
Investment ,
Investors ,
Mergers ,
Private Equity ,
Regulatory Standards ,
Sellers ,
Target Company ,
Transparency ,
Valuation
To increase the likelihood of ultimately closing a transaction with a private equity investor or buyer, the key is preparation. Preparation is divided up into several steps....more